Latham Watkins served as international legal counsel alongside Trilegal as India legal counsel for Platinum Equity in the transaction, while Kirkland & Ellis provided financing counsel...
Platinum Equity’s Acquisition of a Controlling Stake in Inventia Healthcare
Boston Scientific’s $1.26 Billion Acquisition of Silk Road
Latham & Watkins represented Boston Scientific Corporation in the transaction, and Wilson Sonsini Goodrich & Rosati represented Silk Road Medical. Boston Scientific Corporation (“Boston Scientific”) (NYSE:...
Amphenol Corp.’s $2.025 Billion Acquisition of Carlisle Interconnect Technologies
Kirkland & Ellis is advising Carlisle Companies Incorporated on the transaction, and Latham & Walkins is advising Amphenol Corporation. Amphenol Corporation (NYSE: APH), a leading global...
Sanofi, AstraZeneca and Sobi’s Streamlining of Nirsevimab Contractual Arrangements
Latham & Watkins represented Sobi in the transaction. Sanofi has simplified its contractual arrangements relating to the development and commercialization of Beyfortus (nirsevimab) in the United...
Harps Global’s Acquisition of a Medical Division from Semperit
Schoenherr and Latham & Watkins advised Harps Global on the deal. Harps Global PTE. LTD executed the acquisition of the medical business division (Sempermed) from Austrian...
Goldman Sachs Asset Management’s Acquisition of Controlling Stake in Norgine Europe
Latham & Watkins has advised Norgine Europe B.V. on the deal. Allen & Overy and White & Case have advised Goldman Sachs Asset Management Division. Norgine...
Pfizer’s $25 Million Equity Investment in Zentalis Pharmaceuticals
Latham & Watkins represented Zentalis Pharmaceuticals in the transaction. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological...
Theramex’ Licensing Agreement with ObsEva
Latham & Watkins has advised Theramex on the deal. Theramex, a leading global pharmaceutical company specialising in women’s health, announced its licensing agreement with ObsEva SA,...
GlaxoSmithKline’s Collaboration with Alector
Latham & Watkins LLP represented GSK in the transaction. Alector, Inc. and GlaxoSmithKline plc, announced a strategic global collaboration for the development and commercialization of two...
GlaxoSmithKline’s Collaboration with Alector
Latham & Watkins LLP represented GSK in the transaction. Alector, Inc. and GlaxoSmithKline plc, announced a strategic global collaboration for the development and commercialization of two...
Perwyn’s Acquisition of Majority Stake in Jersey Telecom
Appleby, working alongside Eversheds Sutherland LLP, acted for family-backed private equity firm Perwyn in relation to the purchase of the majority stake in Jersey Telecom’s “Internet...
Novo Holdings’ Acquisition Of BBI Group
Allen & Overy advised Exponent Private Equity on the deal. Kromann Reumert and Latham & Watkins assisted Novo Holdings. White & Case advised Goldman Sachs, Golub...